Mallal SA - Search Results

1

Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors.

Sooda A, Rwandamuriye F, Wanjalla CN, Jing L, Koelle DM, Peters B, Leary S, Chopra A, Calderwood MA, Mallal SA, Pavlos R, Watson M, Phillips EJ, Redwood AJ. Sooda A, et al. Among authors: mallal sa. Commun Biol. 2022 Feb 16;5(1):133. doi: 10.1038/s42003-022-03058-9. Commun Biol. 2022. PMID: 35173258 Free PMC article.

2

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.

Martin AM, Nolan D, Gaudieri S, Almeida CA, Nolan R, James I, Carvalho F, Phillips E, Christiansen FT, Purcell AW, McCluskey J, Mallal S. Martin AM, et al. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4180-5. doi: 10.1073/pnas.0307067101. Epub 2004 Mar 15. Proc Natl Acad Sci U S A. 2004. PMID: 15024131 Free PMC article.

3

Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity.

Martin AM, Nolan D, Gaudieri S, Phillips E, Mallal S. Martin AM, et al. Pharmacogenomics. 2004 Sep;5(6):643-55. doi: 10.1517/14622416.5.6.643. Pharmacogenomics. 2004. PMID: 15335286 Review.

4

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts.

Martin AM, Nolan D, James I, Cameron P, Keller J, Moore C, Phillips E, Christiansen FT, Mallal S. Martin AM, et al. AIDS. 2005 Jan 3;19(1):97-9. doi: 10.1097/00002030-200501030-00014. AIDS. 2005. PMID: 15627041

5

Clinical and immunogenetic correlates of abacavir hypersensitivity.

Phillips EJ, Wong GA, Kaul R, Shahabi K, Nolan DA, Knowles SR, Martin AM, Mallal SA, Shear NH. Phillips EJ, et al. Among authors: mallal sa. AIDS. 2005 Jun 10;19(9):979-81. doi: 10.1097/01.aids.0000171414.99409.fb. AIDS. 2005. PMID: 15905681

6

A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome.

Martin AM, Krueger R, Almeida CA, Nolan D, Phillips E, Mallal S. Martin AM, et al. Pharmacogenet Genomics. 2006 May;16(5):353-7. doi: 10.1097/01.fpc.0000197468.16126.cd. Pharmacogenet Genomics. 2006. PMID: 16609367

7

HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.

Lucas A, Nolan D, Mallal S. Lucas A, et al. J Antimicrob Chemother. 2007 Apr;59(4):591-3. doi: 10.1093/jac/dkl557. Epub 2007 Feb 22. J Antimicrob Chemother. 2007. PMID: 17317695

8

Immune responses to abacavir in antigen-presenting cells from hypersensitive patients.

Martin AM, Almeida CA, Cameron P, Purcell AW, Nolan D, James I, McCluskey J, Phillips E, Landay A, Mallal S. Martin AM, et al. AIDS. 2007 Jun 19;21(10):1233-44. doi: 10.1097/QAD.0b013e3280119579. AIDS. 2007. PMID: 17545699

9

Drug hypersensitivity in HIV.

Phillips E, Mallal S. Phillips E, et al. Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):324-30. doi: 10.1097/ACI.0b013e32825ea68a. Curr Opin Allergy Clin Immunol. 2007. PMID: 17620824 Review.

10

External quality assessment of HLA-B*5701 reporting: an international multicentre survey.

Hammond E, Almeida CA, Mamotte C, Nolan D, Phillips E, Schollaardt TA, Gill MJ, Angel JB, Neurath D, Li J, Giulivi T, McIntyre C, Koultchitski G, Wong B, Reis M, Rachlis A, Cole DE, Chew CB, Neifer S, Lalonde R, Roger M, Jeanneau A, Mallal S. Hammond E, et al. Antivir Ther. 2007;12(7):1027-32. Antivir Ther. 2007. PMID: 18018760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page